methylene blue has been researched along with Post-operative Vasoplegic Syndrome in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 47 (67.14) | 24.3611 |
2020's | 23 (32.86) | 2.80 |
Authors | Studies |
---|---|
Bauer, SR; Douglas, A; Hohlfelder, B; Wanek, M; Wang, L | 1 |
Bhutiani, M; Brennan, KA; Kingeter, MA; McEvoy, MD | 1 |
Brokmeier, HM; Gerberi, DJ; Mara, KC; Nei, SD; Seelhammer, TG; Wieruszewski, PM; Wittwer, ED | 1 |
Aldeghaither, S; Deschênes, PJF; Samoukovic, G | 1 |
Arevalo, VN; Bullerwell, ML | 1 |
Dalia, AA; Ortoleva, J; Shapeton, A; Vanneman, M | 1 |
Barker, N; Busse, LW; Petersen, C | 1 |
Aljure, OD; Augoustides, JG; Davis, S; Feinman, JW; Ha, B; Patel, PA; Patel, S; Pulton, D; Restrepo-Cardenas, J; Shah, R; Vasquez, CR; Weiss, SJ; Wenger, RK | 1 |
Flynn, BC; Kidd, B | 1 |
Burns, SL; Saha, BK | 1 |
Colombo, PC; Jennings, DL; Kurlansky, P; Miltiades, AN; Naka, Y; Ning, Y; Saha, A; Sanchez, J; Spellman, JL; Takayama, H; Takeda, K; Yuzefpolskaya, M | 1 |
Basta, MN | 1 |
Brockway, E; Canlas, C; Liao, ZW; Walters, C | 1 |
Annich, G; Ben-Ari, J; Bitterman, Y; Eytan, D; Hadash, A; Hubara, E | 1 |
Chen, F; Dalia, AA; Devine, LT; French, A; Kawabori, M; Ortoleva, J; Roberts, RJ; Shelton, K | 1 |
Aklilu, AM; Avigan, ZM; Brewster, UC | 1 |
Kloping, NA; Kloping, YP; Luke, K; Nugraha, D; Perdhana, F; Rehatta, NM; Witarto, AP; Yogiswara, N | 1 |
Augoustides, JG | 1 |
Finamore, M; Peyko, V | 1 |
Nash, CM | 1 |
Cook, JC; Ghadimi, K; Kram, BL; Kram, SJ; Ohman, KL | 1 |
Allouch, K; Graf, BM; Gruber, M; Petermichl, W; Schoeller, I; Zausig, YA | 1 |
Auxiliadora-Martins, M; Basile, A; Bassetto, S; Evora, PRB; Silva, FLDS; Soares, ROS | 1 |
Albuquerque, AAS; Evora, PM; Evora, PRB; Gonçalves-Ferri, WA | 1 |
Jakobsons, JJ; Khatib, D; Tawil, JN; Woehlck, HJ | 1 |
Ailawadi, G; Charles, EJ; Ghanta, RK; Hawkins, RB; Johnston, LE; Kern, JA; Kron, IL; Mehaffey, JH; Yarboro, L | 1 |
Boettcher, BT; Feih, JT; Freed, JK; Ghadiali, HY; Kaiser, M; Pagel, PS; Rinka, JRG; Tawil, JN; Woehlck, HJ; Zundel, MT | 1 |
Booth, AT; Mehaffey, JH; Melmer, PD; Tribble, B; Tribble, C | 1 |
Abdalla, AM; Becker, T; Buckley, NA; Chan, BS; Chiew, AL; Liu, X; Roberts, MS; Robertson, TA | 1 |
Duce, L; Ghadimi, K; McCartney, SL | 1 |
Augoustides, JGT; Evans, A; Gutsche, J; Ivascu, NS; Klick, J; Mittel, A; Shaefi, S | 1 |
Barbosa Evora, PR | 1 |
Armour, S; Ritter, MJ; Smith, BB; Warner, MA | 1 |
Cakir, H; Celik, E; Gungor, H; Kestelli, M; Yurekli, I | 1 |
Mehaffey, JH | 1 |
Chow, JH; Evans, A; McCurdy, MT; Weiner, M; Zaku, B | 1 |
Cobey, FC; Ortoleva, JP | 1 |
Feih, JT; Rinka, JRG; Zundel, MT | 1 |
Hwang, NC; Zeng, LA | 1 |
Evora, PR | 2 |
Corbi, P; Hajj-Chahine, J; Jayle, C | 1 |
Bergin, JD; Groves, DS; Grubb, KJ; Kennedy, JL; Kern, JA | 2 |
Al-Ghofaily, L; Augoustides, JG; Gregorits, M; Gutsche, JT; Valentine, E | 1 |
Danforth, D; Fischer, GW; Hosseinian, L; Lin, HM; Rao, S; Weiner, MM | 1 |
Fischer, GW; Weiner, MM | 1 |
Celotto, AC; Evora, PR; José Rodrigues, A | 1 |
Di Prima, AL; Dossi, R; Landoni, G; Pasin, L; Taddeo, D; Zangrillo, A | 1 |
Cartner, M; Graham, RE; Winearls, J | 1 |
Benner, K; Brown, B; Hayes, L; Prabhakaran, P; Rutledge, C | 1 |
Attias, O; Ben-Ari, J; Hadash, A; Hershman, E | 1 |
Carley, M; Lai, T; Poppers, J; Schaff, J | 1 |
Brown, L; Manghelli, J; Munfakh, NA; Tadros, HB | 2 |
Ing, C; Lee, JK | 1 |
Fischer, GW; Hosseinian, L; Levin, MA; Weiner, M | 1 |
Hencken, L; Ly, N; Morgan, JA; To, L | 1 |
Castro E Silva, O; Evora, PRB; Mente, ED; Mumic, FT; Silveira, MRG; Vilalva, KH | 1 |
Boettcher, BT; Cronin, DC; Hong, JC; Kim, J; Lauer, KK; Selim, M; Woehlck, HJ; Zimmerman, MA | 1 |
Bengtsson, Y; Cohen, E; Fischer, GW; Scarola, S | 1 |
Lavigne, D | 1 |
Darrow, B; Milla, F; Raikhelkar, JK; Scurlock, C | 1 |
Maysick, L; Raikhelkar, JK; Scurlock, C; Weiss, AJ | 1 |
Andritsos, MJ | 1 |
Augoustides, JG; Riha, H | 1 |
Lenglet, S; Mach, F; Montecucco, F | 1 |
Celotto, AC; da Silva, MF; Evora, PR; Farina Junior, JA | 1 |
Arndt, KL; Lutjen, DL | 1 |
Balireddy, RK; Groves, DS; Thiele, RH | 1 |
20 review(s) available for methylene blue and Post-operative Vasoplegic Syndrome
Article | Year |
---|---|
Updates in the Management of Perioperative Vasoplegic Syndrome.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Liver Transplantation; Methylene Blue; Vasoplegia | 2022 |
Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue.
Topics: Adult; Humans; Hydroxocobalamin; Hypotension; Methylene Blue; Shock; Vasodilation; Vasoplegia | 2023 |
Methylene Blue as an Adjunct to Treat Vasoplegia in Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass: A Literature Review.
Topics: Anesthesia; Coronary Artery Bypass; Humans; Intraoperative Complications; Methylene Blue; Nurse Anesthetists; Randomized Controlled Trials as Topic; Vasoplegia | 2018 |
Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
Topics: Cardiopulmonary Bypass; Humans; Hydroxocobalamin; Methylene Blue; Norepinephrine; Vasoplegia | 2020 |
Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
Topics: Adrenal Cortex Hormones; Angiotensin II; Ascorbic Acid; Cardiac Surgical Procedures; Dopamine; Enzyme Inhibitors; Epinephrine; Humans; Methylene Blue; Norepinephrine; Phenylephrine; Sympathomimetics; Vascular Resistance; Vasoconstrictor Agents; Vasoplegia; Vasopressins | 2020 |
The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
Topics: Humans; Methylene Blue; Nitric Oxide; Shock, Septic; Vasodilation; Vasoplegia | 2020 |
Postoperative Serotonin Syndrome Following Methylene Blue Administration for Vasoplegia After Cardiac Surgery: A Case Report and Review of the Literature.
Topics: Cardiac Surgical Procedures; Cyproheptadine; Enzyme Inhibitors; Humans; Hypnotics and Sedatives; Lorazepam; Male; Methylene Blue; Middle Aged; Neuromuscular Nondepolarizing Agents; Postoperative Complications; Rocuronium; Serotonin Antagonists; Serotonin Syndrome; Vasoplegia | 2021 |
A unique case of purple urine: A case report and literature review.
Topics: Cardiopulmonary Bypass; Humans; Hydroxocobalamin; Male; Methylene Blue; Middle Aged; Pigmentation; Urine; Vasoplegia | 2021 |
Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.
Topics: Adult; Cardiopulmonary Bypass; Hemodynamics; Humans; Methylene Blue; Vascular Resistance; Vasoplegia | 2021 |
Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
Topics: Cardiac Surgical Procedures; Humans; Intraoperative Complications; Methylene Blue; Postoperative Complications; Risk Factors; Vasoplegia | 2021 |
Methylene Blue not Contraindicated in Treating Hemodynamic Instability in Pediatric and Neonate Patients.
Topics: Adolescent; Child; Hemodynamics; Humans; Infant, Newborn; Methylene Blue; Pediatrics; Randomized Controlled Trials as Topic; Vasoplegia | 2022 |
Methylene Blue for Vasoplegic Syndrome.
Topics: Cardiac Surgical Procedures; Enzyme Inhibitors; Humans; Methylene Blue; Postoperative Complications; Vasoplegia | 2017 |
Intraoperative vasoplegia: methylene blue to the rescue!
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Liver Transplantation; Methylene Blue; Vascular Resistance; Vasoplegia | 2018 |
Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
Topics: Angiotensin II; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Methylene Blue; Risk Factors; Vascular Surgical Procedures; Vasoplegia | 2018 |
Clinical update in liver transplantation.
Topics: Anesthesia; Cardiac Surgical Procedures; Humans; Kidney Diseases; Liver Transplantation; Methylene Blue; Postoperative Complications; Reperfusion Injury; Vasoconstrictor Agents; Vasoplegia; Vasopressins | 2013 |
Methylene Blue: Magic Bullet for Vasoplegia?
Topics: Cardiac Surgical Procedures; Cardiovascular Agents; Hemodynamics; Humans; Liver Transplantation; Methylene Blue; Resuscitation; Shock, Septic; Treatment Outcome; Vasodilation; Vasoplegia | 2016 |
Vasopressin and methylene blue: alternate therapies in vasodilatory shock.
Topics: Animals; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Clinical Trials as Topic; Humans; Methylene Blue; Vasoconstrictor Agents; Vasoplegia; Vasopressins | 2010 |
Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Drug Therapy, Combination; Enzyme Inhibitors; Guanylate Cyclase; Humans; Intraoperative Complications; Methylene Blue; Nitric Oxide Synthase; Postoperative Complications; Salvage Therapy; Vasoplegia | 2011 |
Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.
Topics: Animals; Burns; Enzyme Inhibitors; Guanylate Cyclase; Humans; Methylene Blue; Severity of Illness Index; Vasoplegia | 2012 |
The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature.
Topics: Enzyme Inhibitors; Guanylate Cyclase; Heart Transplantation; Humans; Male; Methylene Blue; Middle Aged; Nitric Oxide Synthase; Receptors, Cytoplasmic and Nuclear; Serotonin Syndrome; Soluble Guanylyl Cyclase; Vasoconstrictor Agents; Vasoplegia | 2012 |
50 other study(ies) available for methylene blue and Post-operative Vasoplegic Syndrome
Article | Year |
---|---|
Association of Methylene Blue Dosing With Hemodynamic Response for the Treatment of Vasoplegia.
Topics: Hemodynamics; Humans; Methylene Blue; Norepinephrine; Retrospective Studies; Vasoconstrictor Agents; Vasoplegia | 2022 |
Anticholinergic Toxidrome as a Possible Explanation for Methylene Blue Toxicity.
Topics: Cardiac Surgical Procedures; Heart; Humans; Hypotension; Male; Methylene Blue; Vasoplegia | 2023 |
Severe Vasoplegic Shock During Coronary Artery Bypass Surgery: Therapeutic challenges and Dilemmas in Hemodynamic Rescue.
Topics: Cardiopulmonary Bypass; Coronary Artery Bypass; Hemodynamics; Humans; Methylene Blue; Vasoplegia | 2020 |
Repurposing in 2020: Teaching Old Drugs New Tricks.
Topics: Drug Repositioning; Humans; Hydroxocobalamin; Methylene Blue; Pharmaceutical Preparations; Retrospective Studies; Vasoplegia | 2020 |
Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation.
Topics: Aged; Cardiopulmonary Bypass; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Failure; Heart-Assist Devices; Humans; Male; Methylene Blue; Middle Aged; Postoperative Complications; Propensity Score; Retrospective Studies; Vasoplegia | 2021 |
Hydroxocobalamin for the treatment of refractory intraoperative vasoplegia in a patient with history of squamous cell carcinoma and radiation.
Topics: Carcinoma, Squamous Cell; Cardiopulmonary Bypass; Humans; Hydroxocobalamin; Methylene Blue; Vasoplegia | 2021 |
Methylene Blue Administration for Distributive Shock States in Critically Ill Children.
Topics: Blood Pressure; Child; Child, Preschool; Critical Illness; Fatal Outcome; Female; Humans; Infant; Infant, Newborn; Israel; Male; Methylene Blue; Retrospective Studies; Shock; Shock, Septic; Vasoplegia | 2020 |
Methylene Blue for Vasoplegia During Extracorporeal Membrane Oxygenation Support.
Topics: Extracorporeal Membrane Oxygenation; Humans; Methylene Blue; Prospective Studies; Retrospective Studies; Shock, Cardiogenic; Vasoplegia | 2021 |
Commentary: Angiotensin II: Expanding the rescue options for vasoplegia.
Topics: Angiotensin II; Cardiopulmonary Bypass; Humans; Methylene Blue; Vasoplegia | 2022 |
Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
Topics: Cardiopulmonary Bypass; Humans; Hydroxocobalamin; Hypotension; Methylene Blue; Vasoplegia | 2021 |
Hydroxocobalamin or Methylene Blue for Vasoplegic Syndrome in Adult Cardiothoracic Surgery.
Topics: Adult; Cardiopulmonary Bypass; Cohort Studies; Humans; Hydroxocobalamin; Methylene Blue; Retrospective Studies; Vasoplegia | 2022 |
The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery.
Topics: Aged; Cardiac Surgical Procedures; Female; Humans; Male; Methylene Blue; Middle Aged; Retrospective Studies; Stroke Volume; Vasoplegia; Ventricular Function, Left | 2021 |
After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Hypotension; Methylene Blue; Vasoplegia | 2021 |
Rainbow after the storm.
Topics: Aged; Female; Fluid Therapy; Hematinics; Humans; Hydroxocobalamin; Mediastinitis; Methylene Blue; Resuscitation; Sepsis; Vasoplegia | 2017 |
Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
Topics: Aged; Cardiac Surgical Procedures; Enzyme Inhibitors; Female; Humans; Male; Methylene Blue; Middle Aged; Postoperative Care; Postoperative Complications; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Vasoplegia; Virginia | 2017 |
Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases.
Topics: Adult; Cardiac Surgical Procedures; Critical Illness; Humans; Hydroxocobalamin; Male; Methylene Blue; Vasoplegia; Water-Electrolyte Balance | 2018 |
Vasoplegic Shock Treated with Methylene Blue Complicated by Severe Serotonin Syndrome.
Topics: Adolescent; Antidotes; Depressive Disorder, Major; Drug Interactions; Drug Overdose; Glasgow Coma Scale; Humans; Male; Methylene Blue; Serotonin Syndrome; Suicide, Attempted; Vasoplegia | 2018 |
Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment.
Topics: Cyclic GMP; Drug Discovery; Humans; Methylene Blue; Nitrous Oxide; Soluble Guanylyl Cyclase; Vasoplegia | 2018 |
Cardiopulmonary Bypass Ultrafiltrate Discoloration After Hydroxocobalamin Administration.
Topics: Adult; Blood Loss, Surgical; Cardiopulmonary Bypass; Color; Diagnosis, Differential; End Stage Liver Disease; Enzyme Inhibitors; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Hydroxocobalamin; Male; Methylene Blue; Nitric Oxide Synthase; Pharmaceutical Solutions; Postoperative Complications; Ultrafiltration; Vasoconstrictor Agents; Vasoplegia | 2019 |
Methylene Blue for Vasoplegic Syndrome After Cardiac Operations.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Methylene Blue; Vasoplegia | 2019 |
Reply.
Topics: Humans; Methylene Blue; Vasoplegia | 2019 |
Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.
Topics: Aged, 80 and over; Angiotensin II; Cardiopulmonary Bypass; Humans; Male; Methylene Blue; Vasoplegia | 2019 |
A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy.
Topics: Algorithms; Humans; Hydroxocobalamin; Methylene Blue; Risk Factors; Vasoconstrictor Agents; Vasoplegia | 2019 |
Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
Topics: Aged; Aged, 80 and over; Cohort Studies; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Hydroxocobalamin; Male; Methylene Blue; Middle Aged; Retrospective Studies; Treatment Outcome; Vasoconstrictor Agents; Vasoplegia; Vitamin B Complex | 2019 |
Vasoplegia: More Magic Bullets?
Topics: Cohort Studies; Combined Modality Therapy; Humans; Hydroxocobalamin; Methylene Blue; Vasoplegia | 2019 |
Methylene blue, serotonergic syndrome, and heart transplant.
Topics: Heart Transplantation; Humans; Male; Methylene Blue; Serotonin Syndrome; Vasoconstrictor Agents; Vasoplegia | 2013 |
Methylene blue in patients with severe pulmonary hypertension.
Topics: Heart Transplantation; Humans; Male; Methylene Blue; Serotonin Syndrome; Vasoconstrictor Agents; Vasoplegia | 2013 |
Reply to the editor.
Topics: Heart Transplantation; Humans; Male; Methylene Blue; Serotonin Syndrome; Vasoconstrictor Agents; Vasoplegia | 2013 |
Methylene blue is associated with poor outcomes in vasoplegic shock.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidotes; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Female; Hospital Mortality; Humans; Logistic Models; Male; Methylene Blue; Middle Aged; Postoperative Complications; Propensity Score; Retrospective Studies; Treatment Outcome; Vasoplegia; Young Adult | 2013 |
In response.
Topics: Antidotes; Female; Humans; Male; Methylene Blue; Vasoplegia | 2014 |
"Methylene blue should be relegated to rescue use and not as first-line therapy" cannot become a paradigm.
Topics: Antidotes; Female; Humans; Male; Methylene Blue; Vasoplegia | 2014 |
Methylene blue: between scylla (meta-analysis) and charybdis (propensity).
Topics: Blood Pressure; Cardiac Surgical Procedures; Humans; Meta-Analysis as Topic; Methylene Blue; Propensity Score; Randomized Controlled Trials as Topic; Survival; Vascular Resistance; Vasoplegia | 2014 |
A severe case of vasoplegic shock following metformin overdose successfully treated with methylene blue as a last line therapy.
Topics: Acidosis; Adult; Drug Overdose; Fluid Therapy; Gliclazide; Humans; Male; Metformin; Methylene Blue; Shock; Vasoconstrictor Agents; Vasoplegia | 2015 |
A Novel Use of Methylene Blue in the Pediatric ICU.
Topics: Combined Modality Therapy; Enzyme Inhibitors; Female; Humans; Hypotension; Infant; Methylene Blue; Shock, Septic; Vasoplegia | 2015 |
Methylene blue treatment for resistant shock following renal transplantation.
Topics: Adult; Female; Humans; Kidney Transplantation; Methylene Blue; Postoperative Complications; Shock; Vasoplegia; Young Adult | 2015 |
Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
Topics: Adult; Cardiopulmonary Bypass; Enzyme Inhibitors; Humans; Lung Transplantation; Male; Methylene Blue; Treatment Outcome; Vasoplegia | 2015 |
A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Topics: Aged; Aortic Valve; Cardiac Valve Annuloplasty; Cardiopulmonary Bypass; Enzyme Inhibitors; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Male; Methylene Blue; Mitral Valve; Nitric Oxide; Nitric Oxide Synthase; Time Factors; Treatment Outcome; Vasoplegia | 2015 |
Prothrombin Complex Concentrate and Methylene Blue for Treatment of Coagulopathy and Vasoplegia in a Pediatric Heart Transplant Patient.
Topics: Blood Coagulation Factors; Cardiomyopathy, Dilated; Child; Female; Heart Transplantation; Heart-Assist Devices; Hemorrhage; Humans; Methylene Blue; Perioperative Period; Vasoplegia | 2016 |
Serotonin Syndrome Following Methylene Blue Administration for Vasoplegic Syndrome.
Topics: Citalopram; Drug Synergism; Female; Heart-Assist Devices; Humans; Methylene Blue; Middle Aged; Prosthesis Implantation; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Severity of Illness Index; Vasoplegia | 2016 |
Methylene Blue Is a Guanylate Cyclase Inhibitor That Does Not Interfere with Nitric Oxide Synthesis.
Topics: Aortic Valve; Cardiac Valve Annuloplasty; Cardiopulmonary Bypass; Enzyme Inhibitors; Heart Valve Prosthesis Implantation; Humans; Male; Methylene Blue; Mitral Valve; Nitric Oxide Synthase; Vasoplegia | 2016 |
To the Editor.
Topics: Aortic Valve; Cardiac Valve Annuloplasty; Cardiopulmonary Bypass; Enzyme Inhibitors; Heart Valve Prosthesis Implantation; Humans; Male; Methylene Blue; Mitral Valve; Nitric Oxide Synthase; Vasoplegia | 2016 |
Use of Methylene Blue to Treat Hypovolemic Shock Followed by Ischemia-Reperfusion Injury in the Postoperative Orthotopic Liver Transplant Patient: A Case Report.
Topics: Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Liver Transplantation; Methylene Blue; Middle Aged; Non-alcoholic Fatty Liver Disease; Reperfusion Injury; Shock; Treatment Outcome; Vasoplegia | 2018 |
Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm.
Topics: Blood Pressure; Female; Humans; Hydroxocobalamin; Liver Transplantation; Methylene Blue; Middle Aged; Peripheral Arterial Disease; Treatment Outcome; Vascular Resistance; Vasoplegia | 2016 |
Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation.
Topics: Blood Pressure; Echocardiography, Transesophageal; Hepatitis, Autoimmune; Humans; Intraoperative Complications; Kidney Transplantation; Liver Transplantation; Male; Methylene Blue; Middle Aged; Vascular Resistance; Vasoconstrictor Agents; Vasoplegia | 2010 |
Adjuvant therapy with methylene blue in the treatment of right ventricular failure after pulmonary embolectomy.
Topics: Aged; Chemotherapy, Adjuvant; Embolectomy; Enzyme Inhibitors; Humans; Male; Methylene Blue; Pulmonary Embolism; Vasoplegia; Ventricular Dysfunction, Right | 2011 |
Adjuvant therapy with methylene blue in the treatment of postoperative vasoplegic syndrome caused by carcinoid crisis after tricuspid valve replacement.
Topics: Aged; Carcinoid Heart Disease; Chemotherapy, Adjuvant; Heart Valve Prosthesis Implantation; Humans; Male; Methylene Blue; Treatment Outcome; Tricuspid Valve Insufficiency; Vasoplegia | 2012 |
Con: methylene blue should not be used routinely for vasoplegia perioperatively.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Methylene Blue; Perioperative Period; Risk Factors; Vasoplegia | 2011 |
Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery.
Topics: Cardiac Surgical Procedures; Humans; Methylene Blue; Postoperative Complications; Risk Factors; Vasoplegia | 2011 |
Methylene blue to treat vasoplegia due to a severe protamine reaction: a case report.
Topics: Coronary Artery Bypass; Enzyme Inhibitors; Female; Heparin Antagonists; Humans; Methylene Blue; Middle Aged; Nurse Anesthetists; Protamines; Severity of Illness Index; Vasoplegia | 2012 |
Methylene blue treatment for vasoplegia and resultant isoelectric processed EEG (bispectral index).
Topics: Consciousness Monitors; Electroencephalography; Enzyme Inhibitors; Humans; Male; Methylene Blue; Middle Aged; Vasoplegia | 2012 |